Hydrocortisone plus fludrocortisone for adults with septic shock.
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Septic shock is characterized by dysregulation of the host response to infection, with circulatory, cellular, and metabolic abnormalities. We hypothesized that therapy with hydrocortisone plus fludrocortisone or with drotrecogin alfa (activated), which can modulate the host response, would improve the clinical outcomes of patients with septic shock. METHODS: In this multicenter, double-blind, randomized trial with a 2-by-2 factorial design, we evaluated the effect of hydrocortisone-plus-fludrocortisone therapy, drotrecogin alfa (activated), the combination of the three drugs, or their respective placebos. The primary outcome was 90-day all-cause mortality. Secondary outcomes included mortality at intensive care unit (ICU) discharge and hospital discharge and at day 28 and day 180 and the number of days alive and free of vasopressors, mechanical ventilation, or organ failure. After drotrecogin alfa (activated) was withdrawn from the market, the trial continued with a two-group parallel design. The analysis compared patients who received hydrocortisone plus fludrocortisone with those who did not (placebo group). RESULTS: Among the 1241 patients included in the trial, the 90-day mortality was 43.0% (264 of 614 patients) in the hydrocortisone-plus-fludrocortisone group and 49.1% (308 of 627 patients) in the placebo group (P=0.03). The relative risk of death in the hydrocortisone-plus-fludrocortisone group was 0.88 (95% confidence interval, 0.78 to 0.99). Mortality was significantly lower in the hydrocortisone-plus-fludrocortisone group than in the placebo group at ICU discharge (35.4% vs. 41.0%, P=0.04), hospital discharge (39.0% vs. 45.3%, P=0.02), and day 180 (46.6% vs. 52.5%, P=0.04) but not at day 28 (33.7% and 38.9%, respectively; P=0.06). The number of vasopressor-free days to day 28 was significantly higher in the hydrocortisone-plus-fludrocortisone group than in the placebo group (17 vs. 15 days, P<0.001), as was the number of organ-failure-free days (14 vs. 12 days, P=0.003). The number of ventilator-free days was similar in the two groups (11 days in the hydrocortisone-plus-fludrocortisone group and 10 in the placebo group, P=0.07). The rate of serious adverse events did not differ significantly between the two groups, but hyperglycemia was more common in hydrocortisone-plus-fludrocortisone group. CONCLUSIONS: In this trial involving patients with septic shock, 90-day all-cause mortality was lower among those who received hydrocortisone plus fludrocortisone than among those who received placebo. (Funded by Programme Hospitalier de Recherche Clinique 2007 of the French Ministry of Social Affairs and Health; APROCCHSS ClinicalTrials.gov number, NCT00625209 .).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [478]
In the citing paper
“In APROCCHSS [478] the dose of vasopressor was ≥ 0.25 µg/kg/min or ≥ 1 mg/h of norepinephrine or epinephrine, or any other vasopressor for at least 6 h to maintain a MAP ≥ 65 mmHg.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [478]
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [478]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationVincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Self-citationShankar-Hari, M., Phillips, G. S., Levy, M. L., Seymour, C. W., Liu, V. X., Deutschman, C. S., Angus, D. C., Rubenfeld, G. D., Singer, M., & for the Sepsis Definitions Task Force (2016) · JAMA · doi:10.1001/jama.2016.0289 · Cited by 2,424
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Self-citationAnnane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Self-citationAnnane, D., Vignon, P., Renault, A., Bollaert, P.-E., Charpentier, C., Martin, C., Troché, G., Ricard, J.-D., Nitenberg, G., Papazian, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61344-0 · Cited by 567
Self-citationCognitive decline after sepsis.
Annane, D., & Sharshar, T. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70246-2 · Cited by 290
Self-citation
Research works printed but not linked: 1
- Guide “100 recommandations pour la surveillance et la préventions des infections nosocomiales.” Bulletin Epidémiologique Hebdomadaire. No. 48. November 30 1992 (http://invs.santepubliquefrance.fr/beh/1992/48/index.html).
Cited by
Items 701–800 of 968
Infecciones respiratorias con compromiso respiratorio. Neumonías y COVID-19
Blanco, I. M., Giménez, D. M., Berián, L. A., & Pérez, J. M. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.10.002 · Cited by 1
Dembek, K. A., Hostnik, L. D., Burns, T. A., & Toribio, R. E. (2024) · Wiley eBooks · doi:10.1002/9781119617228.ch21 · Cited by 2
Role of corticosteroids in the treatment of critically ill sepsis patients: a meta-analysis review
Song, Y., Hao, J., & Liu, Y. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01426-3 · Cited by 1
Heterogeneity, Bayesian thinking, and phenotyping in critical care: A primer
Jones, T. W., Hedrick, T., & Chase, A. M. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae139 · Cited by 1
Steroids in acute respiratory distress syndrome: A panacea or still a puzzle?
Sinha, S., Patnaik, R., & Behera, S. K. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i2.91225 · Cited by 2
Was ist gesichert in der Therapie der Sepsis? Ein Update
Hillebrand, U., Rex, N., Seeliger, B., Stahl, K., & Schenk, H. J. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01794-0 · Cited by 1
Is fludrocortisone the missing piece in septic shock? A closer look
Luo, M., & Wan, Z. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07672-5 · Cited by 1
“Moreover, the observed 28-day mortality rate in the study was substantially lower than rates reported in previous randomized trials (11–24% vs 36.3% in the APROCCHSS trial) [2].”
InfluentialMajor Publications in the Critical Care Pharmacotherapy Literature: 2023
Murray, B., Athale, J., BALK, R. A., Behal, M. L., Brown, J. E., Chanas, T., Dumitru, R. C., Gifford, D. C., Hohlfelder, B., Jones, H. M., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001162 · Cited by 2
Systematic Review on Impacts of Vitamin C, Thiamin, and Hydrocortisone in Sepsis
Khan, A., & Tidman, M. M. (2025) · Journal of Health and Medical Sciences · doi:10.31014/aior.1994.08.01.335 · Cited by 1
Gruccio, P., Girard, W. S., Badipour, A. D., Kakande, R., Adejayan, V., Zulfiqar, M., Ndyomugabe, M., Ojuman, P., Heysell, S. K., Null, M. D., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004429 · Cited by 1
“Different timing and variability in host-response subphenotypes may explain some of the variability in clinical trials of corticosteroids in sepsis [74–78].”
Corticosteroid Treatment in Septic Shock
Liu, J., Xing, Q., Pan, X., Zhang, S., Chen, D., & Annane, D. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2694-4823 · Cited by 1
Self-citationMolendijk, A. J., & Koenderman, L. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag068 · Cited by 1
Wątroba, S., & Bryda, J. (2019) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/114123 · Cited by 1
Steroide in der Infektionsmedizin
Spinner, C. D., Barton, J., Biever, P. M., Klein, M., Rieg, S., Schneider, J., Thoden, J., Wagner, D., & Kern, W. V. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1302-3530 · Cited by 1
“Die beiden jüngsten größeren klinischen Studien zur Thematik Steroide und septischer Schock stammen aus dem Jahre 2018: die australischneuseeländische ADRENAL-Studie und die französische APROCCHSS-Studie [6, 7].”
BackgroundIch glaube nur der Statistik, die ich selbst gefälscht habe
Leistner, R. (2019) · Krankenhaushygiene up2date · doi:10.1055/a-0975-1110 · Cited by 1
“Die Publikationen stellen die Ergebnisse zweier randomisierter, placebokontrollierter Studien (RCT) mit insgesamt knapp 5000 eingeschlossenen Patienten dar [1, 2].”
BackgroundIndependent Clinical Criteria in Medicine
Russell, J. A. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.01.002 · Cited by 1
Monotherapy or Combination Therapy for Septic Shock? A Debate on Steroids
Tsolaki, V., & Siempos, I. Ι. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0175ed · Cited by 1
Tan, D., Zhang, P., Zheng, T. M., Liang, K. Y. H., Su, C., Chen, Y., Lu, T., Richards, J. B., Chong, A. Y.-Y., Lawler, P. R., et al. (2026) · medRxiv · doi:10.64898/2026.03.25.26349312 · Cited by 1
Management of Sepsis and Septic Shock
Sagana, R. L., & Hyzy, R. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-43341-7_53
Kombination aus Hydrokortison und Fludrokortison verbessert Überlebenschancen
Meisel, A. (2018) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-018-2635-5
Misset, B. (2018) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2018.08.018
Self-citationPeeters, B., Meersseman, P., Perre, S. V., Pieter, J. W., Vanmarcke, D., Debaveye, Y. A., Billen, J., Vermeersch, P., Langouche, L., & Greet, V. D. B. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.57.019
Simulating Acute Bacterial Meningitis
Hocker, S. E., & Wijdicks, E. F. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55134-2.00015-4
Corticosteroid Therapy for Septic Shock and Pediatric ARDS
Jacobs, L., Wong, H. R., & Menon, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-96499-7_16
Actualités sur le sepsis et le choc septique de l’enfant
Morin, L., Pierre, A., Tissières, P., Miatello, J., & Durand, P. (2018) · Médecine Intensive Réanimation · doi:10.3166/rea-2018-0080
Adrenal Emergencies in Critically Ill Cancer Patients
Richard, R. P., Grishaw, J. A., & Enfield, K. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-74698-2_81-1
Modern Critical Care Endocrinology and Its Impact on Critical Care Medicine
Bellomo, R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.01.001
2018 Year in Review in Critical Care
Arabi, Y. M., Gouda, A., & Ali, Y. (2019) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_72_19
“The APROCCHSS[6] trial included patients who were experiencing more severe shock and on higher doses of vasopressors compared to ADRENAL.”
Sepsis like a severe complication of autoimmune liver disease in gastroenterological patients
Yakushev, A. A., Федоров, И. Г., Ilchenko, L. Y., Shmycova, S. S., Rautbard, S. A., Orlov, S. U., Nikitin, I. G., & Salicov, A. V. (2019) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2019-9-2-145-151
Once or Twice Daily Screening for Weaning the Critically Ill—Have We Set Our Sights Too Low?*
Genga, K. R., Boyd, J. H., & Russell, J. A. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003737
Hypoglycemia and Hyperglycemia in Critically Ill Cancer Patients
Oğuz, S. H., Ünlütürk, U., Laçin, Ş., Gürlek, A., & Yalçın, Ş. (2019) · Springer eBooks · doi:10.1007/978-3-319-74698-2_89-1
Annane, D., Bollaert, P., Demoule, A., Mira, J. P., Monnet, X., Teboul, J., & Vieillard‐Baron, A. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2019-0112
Self-citationOstro, B., King, A., Branditz, L. D., Martín, D. E. A., Bachmann, D., Panchal, A. R., & Barrie, M. G. (2019) · Journal of Education and Teaching in Emergency Medicine · doi:10.5070/m543044551
Jarczak, D., & Nierhaus, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-17148-3_23
Fernandez, P. A., & Luis, X. (2019) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 4
The Impact of Corticosteroids on Mortality in Adult Patients with Septic ShockPreprint
Henriques, A. (2019) · doi:10.28971/532019ha94 · Cited by 1
“The study by Annane et al. (2018) was the only study that used this corticosteroid in addition to hydrocortisone and the only study demonstrating a decrease in mortality rates.”
BackgroundMethodResultInfluentialHow does critical illness alter metabolism?
Nunnally, M., & Piper, G. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64068-8.00072-9
Current sepsis research: What nurses need to know
Seckel, M. A. (2020) · Nursing Critical Care · doi:10.1097/01.ccn.0000654796.79252.dc
Dargent, A. (2019) · theses.fr (ABES) · doi:10.70675/c64f4229z1115z436azaec5z79486258b620
Self-citationMarino, L. O. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-10032020-124048
Rétrovirus endogènes humains et réponse immunitaire de l’hôte suite à une agression inflammatoire
Tabone, O. (2019) · theses.fr (ABES) · doi:10.70675/4ac9fa66zd0aaz4515za321z881a77c8279e · Cited by 1
Corticosteroids in the Treatment of Sepsis
Allen, R. W., & Tepler, P. (2020) · Academic Emergency Medicine · doi:10.1111/acem.14057
Nouveautés dans les traitements du choc septique et état de la recherche
Herzog, N., Jouquand, F., Aries, P., Giacardi, C., & Rouault, M. (2020) · La Revue de l Infirmière · doi:10.1016/s1293-8505(20)30145-7
Тhe use of corticosteroids in patients with severe burn injuries
Lytovchenko, A., Belozоrov, I., Kudrevych, O. M., Lytovchenko, O., Protsenko, O. S., & Matvieienko, M. S. (2020) · Actual problems of modern medicine · doi:10.26565/2617-409x-2020-5-07
“Необходимо отметить, что в начале исследования пациенты этой группы также получали активированный протеин С (дротрекогин альфа активированный), но в дальнейшем последний был из лечения исключен [46].”
SLPI and soluble BTLA as immunological markers in severe bacterial infections
Lange, A. (2020) · DiVA (Digitala Vetenskapliga Arkivet)
Mittal, A., & Soneja, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-4039-4_2
Vitamin C, Thiamine and Steroids: Ménage à Trois or Medical Masala
Fonseca, A. J. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23538
The Year in Cardiothoracic Critical Care: Selected Highlights from 2019
Gutsche, J. T., Grant, M. C., Kiefer, J., Ghadimi, K., Lane-Fall, M. B., & Mazzeffi, M. A. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.09.114
Low dose corticosteroids in COVID-19 with refractory shock: We are not sure?
Omar, A. S. (2020) · World Journal of Anesthesiology · doi:10.5313/wja.v9.i1.1
Important publications in intensive care in 2018/2019
Šrámek, V., Čundrle, I., Suk, P., Helán, M., & Hruda, J. (2020) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2019.074
[Medication during severe infections].
Workum, J. D., Huysmans, F. T. M., de Mast, Q., den Broeder, A. A., & Kramers, C. (2020) · PubMed
Interpretation of the endocrinology of hospital inpatients
Hanafy, A., Seejore, K., Lynch, J. M., & Murray, R. D. (2021) · British Journal of Hospital Medicine · doi:10.12968/hmed.2020.0517
The vitamin C, thiamine and steroids (VICTAS) in sepsis
Akkaya, P. N. (2020) · Demiroglu Science University Florence Nightingale Transplantation Journal · doi:10.5606/dsufnjt.2020.011
“As a result of these studies on steroid use, different results were obtained in terms of mortality benefits when additional steroids were used.[18-22] While CORTICUS and ADRENAL studies did not show a mortality benefit, both showed that septic shock was reversed more rapidly with hydrocortisone use.”
BackgroundResultInfluentialRaman, S., & Peters, M. J. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198794592.003.0001
Shiba, H., Minami, S., & Shiraishi, A. (2021) · CHEST Journal · doi:10.1016/j.chest.2020.08.2100
Sepsis – hämodynamische Instabilität
Reitgruber, D., & Auer, J. (2021) · Springer eBooks · doi:10.1007/978-3-662-61823-3_35
Marjanović, V., Budić, I., Ignjatijević, S., Stevic, M. M., & Simić, D. (2020) · Timocki medicinski glasnik · doi:10.5937/tmg2004153m
Lambermont, B. C., Ernst, M., Demaret, P., Boccar, S., Fraipont, V., Gurdebeke, C., Brussel, C. V., Quinonez, M., Dubois, C. J. J., Lemineur, T., et al. (2020) · doi:10.21203/rs.3.rs-52427/v1
“Additionally, despite concerns that corticosteroids increase the risk of secondary infections, their use was also shown bene cial as an adjunctive treatment of septic shock [27].”
BackgroundSelf-citationLiang, H., Song, H., Song, G., Li, H., Ding, X., Kan, Q., & Sun, T. (2021) · Research Square · doi:10.21203/rs.3.rs-508536/v1
“Type of Patients Population Sepsis or Septic Shock De nition Experimental Intervention Reported Outcome Annane et al (2018) RCT M NA 1241/614 CS:66 PC:66 415/826 Septic shock Sepsis3.”
BackgroundInfluentialVitamin C – neue Therapiemöglichkeit bei Sepsis?
Müller, S., Wiesmann, T., Wulf, H., & Arndt, C. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1109-4363
“Die Autoren dieser Arbeit sehen andererseits in ihren Ergebnissen Hinweise auf mögliche Vorteile einer i. v., hochdosierten Monotherapie mit Vitamin C.”
BackgroundKayaaltı, S., & Kayaaltı, Ö. (2021) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-021-00132-y
Wang, L., Ma, X., He, H., Su, L., Guo, Y., Shan, G., Wang, Y., Zhou, X. Q., Liu, D., & Long, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-796292/v1
“1%, among which multiple organ dysfunction syndrome was an important cause of death(12).”
BackgroundPredictive Role of Hypernatremia for Acute Kidney Injury in Patients with SepsisPreprint
Zhi, D., Lin, J., Dong, L., Ji, X., Zhuang, H., Liu, Z., Liu, J., & Duan, M. (2019) · doi:10.21203/rs.2.19648/v1
“Another large RCT named Activated Protein C and Corticosteroids for Human Septic Shock (APROCCHSS) trial showed that hydrocortisone plus fludrocortisone of low doses reduced 90-day mortality among patients with septic shock[24].”
BackgroundWu, Y., Lin, C.-K., Hamaya, R., Huang, F.-Y., Chien, Y.-S., Hsu, Y., Chen, S., & Papatheodorou, S. (2021) · medRxiv · doi:10.1101/2021.10.17.21265100
“Bollaert 1998(39) 41 (2) All patients required vasopressors HC 100mg/8h with taper dose until shock reversal with additional days for taper dose Placebo Shock reversal at day 7”
BackgroundMethodInfluentialChandrasekharan, S., Mistry, R., & Frei, D. R. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198853053.003.0038
Shock and Fluid Responsiveness
Hanna, E. B. (2022) · Wiley eBooks · doi:10.1002/9781119832737.ch22
Endocrinology in the Critically Ill
den Berghe, G. V., & Langouche, L. (2022) · doi:10.1093/med/9780198870197.003.0204
Jha, V. K., & Mahapatra, D. K. (2022) · APIK Journal of Internal Medicine · doi:10.4103/ajim.ajim_30_21
James, D., & Prabhakaran, K. (2022) · Wiley eBooks · doi:10.1002/9781119756781.ch47
Sepsis and the Inflammatory Response to Injury
Shnaydman, I., & Bronstein, M. E. (2022) · Wiley eBooks · doi:10.1002/9781119756781.ch5
Infection, sepsis, and multiorgan dysfunction syndrome
Vincent, J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849346.003.0071
Adrenal Emergencies in Critically Ill Cancer Patients
Richard, R. P., Grishaw, J. A., & Enfield, K. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-74588-6_81
Gale, S. E. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.shock_overview
PESQUISA-AÇÃO: A IMPORTÂNCIA DE AÇÕES EDUCATIVAS SOBRE O CUIDADO COM O RECÉM-NASCIDO
Raposo, H. L. O., Silva, R. R. V., Costa, S. M. S., Silva, C. P. O., dos Santos, E. R. S., da Silva, A. N., Batista, A. K. R., & do Lago, L. B. (2020) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0000218
Venkatesh, B., & Cohen, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004014
Management of Sepsis and Septic Shock
Sagana, R. L., & Hyzy, R. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_60 · Cited by 1
When Should Perioperative Glucocorticoid Replacement Be Administered?
Kozarek, K., & Head, D. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77846-6.00026-4
Key Advances in Intensive Care and the Coronavirus Disease-19 Research and Practice Boost
Mentzelopoulos, S. D., & Adamos, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123370
69/m mit rezidivierender Sigmadivertikulis, Tachypnoe und Vigilanzminderung
Mück, A., & Herter, T. (2022) · Die Anaesthesiologie · doi:10.1007/s00101-022-01146-3
Utilidad de los corticoides en el choque séptico
Vargas, J., & Montalvo, M. (2022) · Revista Ecuatoriana de Ciencia Tecnología e Innovación en Salud Pública · doi:10.31790/inspilip.v6iespecial.323
Barbosa, C. S., de Oliveira, T. S., de Vasconcelos, A. C. S., de Oliveira, A. D., de Abreu, C. M. R., da Silva, T. A., Borba, T. D. S., & Silva, V. M. D. O. (2022) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e11420.2022
Desprescrição de medicamento em unidade de terapia intensiva de um hospital universitário do Ceará
Oliveira, A. V., CORTEZ, R. V., Chaves, E. F., Magalhães, L. M., Borges, R. N., Conceição, A. M., de Andrade, C. C., Neto, J. M. D. A., & Silva, H. R. E. (2022) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2022.134.0851
De patiënt met koorts en algehele malaise
de Groot, B., Verdonschot, R. J. C. G., Linzel, D. S., Bouma, H. R., van Beers, E. J., & Kaasjager, K. A. H. (2023) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2805-5_30
Two Curves Diverged—Has That Made All the Difference?*
Maslove, D. M., & Veldhoen, R. A. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005770
Mady, A. M., Abdulrahman, B., Mumtaz, S. A., Al-Odat, M. A., Kuhail, A., Altoraifi, R., Alshae, R., Alharthy, A. M., Karakitsos, D., & Aletreby, W. (2022) · PubMed Central · doi:10.2478/rjaic-2022-0001
Heming, N., & Annane, D. (2023) · Lessons from the ICU · doi:10.1007/978-3-031-17572-5_16
Self-citationZubaidi, M., Isa, M., & Nurrasyidah, I. (2023) · Berkala Kedokteran · doi:10.20527/jbk.v19i1.15708
Corticosteroids in Sepsis: The Enduring Debate
Chacko, J., Pawar, S., Seppelt, I., & Brar, G. (2023) · Springer eBooks · doi:10.1007/978-981-19-9940-6_15
Mejia-Vilet, J. M., Toro-Cisneros, N. D., Caballero-Islas, A. E., Martinez-Rueda, A. J., Hernández-Flores, J., Proaño-Zamudio, J. A., Sacoto-Romo, V. M., Fernández-Camargo, D. A., Comunidad-Bonilla, R. A., Navarro-Gerrard, M. A., et al. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000034
Antimicrobial stewardship: un imperativo per il futuro
Santini, C., & Giusti, M. (2023) · Italian Journal of Medicine · doi:10.4081/itjm.q.2023.2
Research Progress of Drug Treatment of Severe Pneumonia
常, 朝. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361291
Bloos, F. (2023) · Intensivmedizin up2date · doi:10.1055/a-2068-7305
Critical illness-related corticosteroid insufficiency
Burkitt, J. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-76469-8.00090-3
Resuscitation and Preparation of the Emergency General Surgery Patient
Waibel, B. H., & Kamien, A. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.05.011
Corticosteroids in Emergency Pathologies
Radenković, M., & Milićević, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.112317
Management of endocrine disorders in the surgical intensive care unit
Nunn, A. M., & Lee, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-69787-3.00121-0 · Cited by 1
Wiel, É., Vromant, A., & Fakih, R. (2023) · EMC - Urgenze · doi:10.1016/s1286-9341(23)47926-4
Dietrich, M., Bernhard, M., Beynon, C., Fiedler, M. O., Hecker, A., Jungk, C., Nußhag, C., Michalski, D., Schmitt, F. C. F., Brenner, T., et al. (2023) · Die Anaesthesiologie · doi:10.1007/s00101-023-01334-9
Metadata
- Authors
- Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., Timsit, J.-F., Misset, B., Ali Benali, M., Colin, G., Souweine, B., Asehnoune, K., Mercier, E., Chimot, L., Charpentier, C., François, B., Boulain, T., Petitpas, F., Constantin, J.-M., Dhonneur, G., Baudin, F., Combes, A., Bohé, J., Loriferne, J.-F., Amathieu, R., Cook, F., Slama, M., Leroy, O., Capellier, G., Dargent, A., Hissem, T., Maxime, V., & Bellissant, E.
- Affiliations
- Inserm (FR)
- From Service de Médecine Intensive et Réanimation, Hôpital Raymond Poincaré, Garches (D.A., V.M.), Laboratory of Infection and Inflammation Unité 1173, University of Versailles Saint-Quentin-en-Yvelines, INSERM, Montigny-le-Bretonneux (D.A.), Service de Pharmacologie Clinique–Centre d’Investigation Clinique (CIC) INSERM 1414, Centre Hospitalier Universitaire (CHU) de Rennes–Université de Rennes 1, Hôpital Pontchaillou, Rennes (A.R., E.B.), Service de Réanimation Médicale (C.B.-B.) and Service...
- ORCID
- Annane, Djillali
- Renault, Alain
- Quenot, Jean-Pierre
- Siami, Shidasp
- Cariou, Alain
- Forceville, Xavier
- Schwebel, Carole
- Misset, Benoît
- Souweine, Bertrand
- Asehnoune, Karim
- François, Bruno
- Boulain, Thierry
- Constantin, Jean-Michel
- Combes, Alain
- Bohé, Julien
- Amathieu, Roland
- Cook, Fabrice
- Slama, Michel
- Capellier, Gilles
- Dargent, Auguste
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03
- Volume
- 378
- Issue
- 9
- Pages
- 809-818
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2794125559
- Cited by
- 939
- References
- 22
- Citations by year
- 2026: 107 · 2025: 104 · 2024: 97 · 2023: 115 · 2022: 101 · 2021: 98 · 2020: 121 · 2019: 123 · 2018: 70
- FWCI
- 80.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Funders
- Ministère des Affaires Sociales et de la Santé (Programme Hospitalier de Recherche Clinique / P 07)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- cortisol, fludrocortisone, drotrecogin alfa (activated), corticosteroid therapy, host response to infection, 90-day mortality, vasopressor-free days, organ failure, mechanical ventilation, intensive care unit discharge, sepsis treatment
- MeSH terms
- Simplified Acute Physiology Score, Aged, Anti-Inflammatory Agents, Cause of Death, Combined Modality Therapy, Double-Blind Method, Drug Therapy, Combination, Female, Fludrocortisone, Humans, Hydrocortisone, Male, Middle Aged, Recurrence, Respiration, Artificial, Shock, Septic, Survival Analysis, Treatment Outcome, Renal Replacement Therapy, Organ Dysfunction Scores
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.